EMD 6.67% 3.2¢ emyria limited

Ann: Phase 1 trial commences Q1, 2022 for Emyrias ultra-pure CBD, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,747 Posts.
    lightbulb Created with Sketch. 172
    I found this part really interesting, "recently completed animal studies evaluating EMD-RX5 suggest that it has improved bioavailability compared to Epidyolex". Basically you can ingest less and still have the same or greater CBD therapeutic benefit, pretty exciting stuff.

 
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.